Rate Video

EORTC CLTF 2021 | Recent advances in understanding and managing CTCL

Robert Knobler • 15 Oct 2021

EORTC CLTF 2021

Cutaneous T-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma Rare Diseases Antibodies Mogamulizumab

Robert Knobler, MD, Medical University of Vienna, Vienna, Austria, comments on recent advances in the understanding and management of cutaneous T-cell lymphoma (CTCL). This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

Extracorporeal photopheresis for the treatment of CTCL

Robert Knobler • 15 Oct 2021

ECP for cutaneous lymphoma: current landscape & first prospective trial

Robert Knobler • 28 Sep 2018

Related Videos

Novel therapies in the pipeline at Cellectis

Roman Galetto • 14 May 2022

The promise of antibody-drug conjugates for the treatment of multiple myeloma

Mohamad Mohty • 13 May 2022

Recent advances in Waldenström’s macroglobulinemia

Steven Treon • 12 May 2022

CD30-directed CAR-Ts co-expressing CCR4 in R/R HL and CD30+ CTCL

Natalie Grover • 28 Apr 2022